Hot off the Press Archive

Welcome to our archive of previously highlighted papers. 

TOPICS

  • Acute Respiratory Failure
  • COVID-19
  • Novel Therapies
  • Outcomes
  • Sepsis
  • Stem Cell Transplant
  • Surgical Oncology

ACUTE RESPIRATORY FAILURE

Lemiale V, Dumas G, Demoule A, et al. Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure.

 Ann Intensive Care. 2021;11(1):17.

Mokart D, Darmon M, Schellongowski P, et al. Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status.

Ann Intensive Care. 2020;10(1):146.

Lemiale V, De Jong A, Dumas G, et al. Oxygenation Strategy During Acute Respiratory Failure in Critically-Ill Immunocompromised Patients.

Crit Care Med. 2020;48(9):e768-e775.

Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis.

JAMA. 2020;324(1):57-67.

CARE ORGANIZATION

Hourmant Y, Kouatchet A, Lopez R, et al. Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset.

J Crit Care. 2021;62:6-11.

Azoulay É, Soares M, Lengliné É. Preempting critical care services for patients with hematological malignancies. 

Intensive Care Med. 2021;47(10):1140-1143.

COVID-19

Desai A, Gupta R, Advani S, et al. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies.

Cancer. 2020.

Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.

Blood. 2020;136(25):2881-2892.

NOVEL THERAPIES

Gutierrez C, Brown ART, Herr MM, et al. The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities.

J Crit Care. 2020;58:58-64.

Brown ART, Jindani I, Melancon J, et al. ICU Resource Use in Critically III Patients following Chimeric Antigen Receptor T-Cell Therapy.

Am J Respir Crit Care Med. 2020;202(8):1184-1187.

Joseph A, Simonaggio A, Stoclin A, et al. Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit.

Ann Intensive Care. 2020;10(1):143.

OUTCOMES

Benoit DD, van der Zee EN, Darmon M, et al. Outcomes of ICU patients with and without perceptions of excessive care: a comparison between cancer and non-cancer patients. 

Ann Intensive Care. 2021;11(1):120. Published 2021 Jul 31.

Ferreyro BL, Scales DC, Wunsch H, et al. Critical illness in patients with hematologic malignancy: a population-based cohort study. 

Intensive Care Med. 2021;47(10):1104-1114.

Dumas G, Lemiale V, Rathi N, et al. Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis. 

Dumas G, Lemiale V, Rathi N, et al. Am J Respir Crit Care Med. 2021;204(2):187-196.

Vincent F, Soares M, Mokart D, et al. In-hospital and day-120 survival of critically ill solid cancer patients after discharge of the intensive care units: results of a retrospective multicenter study-A Groupe de recherche respiratoire en reanimation en Onco-Hematologie (Grrr-OH) study.

Ann Intensive Care. 2018;8(1):40.

Zampieri FG, Romano TG, Salluh JIF, et al. Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study.

Intensive Care Med. 2021;47(2):170-179.

Munshi L, Darmon M, Soares M, et al. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.

Biol Blood Marrow Transplant. 2020.

Hourmant Y, Kouatchet A, Lopez R, et al. Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset.

J Crit Care. 2021;62:6-11.

Darmon M, Bourmaud A, Georges Q, et al. Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data.

Intensive Care Med. 2019;45(7):977-987.

Pastores SM, Goldman DA, Shaz DJ, et al. Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.

Cancer. 2018;124(14):3025-3036.

Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS. Characteristics and Outcomes of Surgical Patients With Solid Cancers Admitted to the Intensive Care Unit.

JAMA Surg. 2018;153(9):834-840.

SEPSIS

Bou Chebl R, Safa R, Sabra M, et al. Sepsis in patients with haematological versus solid cancer: a retrospective cohort study.

BMJ Open. 2021;11(2):e038349.

Lemiale V, Pons S, Mirouse A, et al. Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study.

Crit Care Med. 2020;48(6):822-829.

Mirouse A, Vigneron C, Llitjos JF, et al. Sepsis and Cancer: An Interplay of Friends and Foes.

 Am J Respir Crit Care Med. 2020;202(12):1625-1635.

STEM CELL TRANSPLANT

Herasevich S, Frank RD, Bo H, et al. Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell Transplantation.

Ann Am Thorac Soc. 2021 Jun;18(6):1004-1012.

Pichereau C, Lengline E, Valade S, et al. Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneichematopoietic stem cell recipients: the Allo-GRRR-OH score.

Bone Marrow Transplant. 2020;55(10):1966-1974.

SURGICAL ONCOLOGY

Tillmann BW, Hallet J, Guttman MP, et al. A Population-Based Analysis of Long-Term Outcomes Among Older Adults Requiring Unexpected Intensive Care Unit Admission After Cancer Surgery.

Ann Surg Oncol. 2021 Aug 24.